6
H. GAO ET AL.
which suggests that meso-(2-benzimidazolyl) BODIPY
can be used as a good platform for post modification to
achieve NIR dyes for various applications in material and
biological sciences.
Preparation of BODIPYs (3a–3c). Dipyrromethane
2a (1.00 mmol, 1.0 equiv.) was dissolved in dry
dichloromethane (60.0 mL) under a N2 atmosphere. The
reaction mixture was cooled to -20°C. A suspension
of DDQ (1.1 mmol, 1.1 equiv.) in a mixed solution of
2.00 mL toluene and 2.00 mL dichloromethane was added
to the previous mixture. Stirring continued for 15 min at
-20°C. After cooling to -78°C, 1, 8-diazabicyclo[5.4.0]
undec-7-ene (DBU) (10.0 mmol, 10 equiv.) was added
dropwise under vigorous stirring. After stirring for 5 min,
EXPERIMENTAL
Instrumentation and materials
All chemical reagents were obtained from commercial
suppliers and used directly, unless otherwise mentioned.
The NMR spectra of all compounds were measured
on a Bruker DRX 500 or 400 spectrometer at 298k
and referenced to the residual proton signals of the
CD3Cl or DMSO-d6. The HR-MS data were recorded
(in negative ion mode) on an Agilent 6540 Q-TOF LC/
MS spectrometer. All the solvents employed for the
spectroscopic measurements were of UV spectroscopic
grade (Aldrich).
.
BF3 OEt2 (15.0 mmol, 15 equiv.) was added dropwise
and stirring continued for 5 min. Finally, the reaction
mixture was allowed to warm to room temperature
and stirred for a further 1 h. The reaction mixture was
quenched by distilled water. The resulting solution was
extracted with dichloromethane. The organic layer was
dried over Na2SO4 and evaporated to dryness under
vacuum. The crude residue was separated by column
chromatography (silica gel, petroleum ether/25% ethyl
acetate), eluting 3a as a strongly fluorescent fraction
and recrystallized from dichloromethane/n-hexane to
give 3a as an orange solid. Yield 168 mg (50%). 3a:
1H NMR (500 MHz, DMSO-d6) d: 7.78–7.69 (m, 2H),
7.36 (dd, J = 5.7, 3.6 Hz, 4H), 6.56 (d, J = 4.2 Hz, 2H),
2.59 (s, 6H). 13C NMR (126 MHz, DMSO-d6) d: 158.35,
144.94, 133.03, 131.81, 128.80, 123.58, 120.59, 14.74.
HR-MS (ESI-Q-TOF): m/z C18H14BF2N4-[M–H]- calcd.
335.1285, found 335.1288.
Synthesis
Preparation of dipyrromethanes (2b–2c). 2-Hydroxy-
methylbenzimidazole 1b (2.50 mmol, 1.0 equiv.) was
added to a solution of 2-iodoxybenzoic acid (IBX)
(2.75 mmol, 1.1 equiv.) in 5 mL dimethyl sulfoxide
(DMSO). The mixture was stirred at room temperature
under N2 atmosphere overnight. Next the reaction mixture
was diluted with 10.0 mL N-methyl-2-pyrrolidone
(NMP). Trifluoroacetic acid (TFA) (1.50 mmol, 0.6
equiv.) was added and subsequently the 2-methylpyrrole
(7.50 mmol, 3.0 equiv.) as liquid diluted with little NMP.
Stirring continued for 8 h at room temperature under a N2
atmosphere.Afterwards, the reaction mixture was washed
with saturated NaHCO3 solution first, then with saturated
NaCl solution to remove the remainders of DMSO and
NMP with high boiling points and extracted with ethyl
acetate. The organic layer was dried over Na2SO4 and
evaporated to dryness under vacuum. Finally, the crude
product was purified by column chromatography (silica
gel, dichloromethane/0.5% methanol) and recrystallized
from dichloromethane/n-hexane to give 2b as pink
Compounds 3b and 3c were obtained by following a
procedure similar to that of 3a in 53% and 58% yield,
1
respectively. 3b: H NMR (400 MHz, DMSO) d: 13.38
(b, 1H), 7.91–7.37 (m, 2H), 7.33 (d, J = 4.0 Hz, 2H),
7.30–7.13 (m, 1H), 6.55 (d, J = 4.1 Hz, 2H), 2.59
(s, 6H). 13C NMR (126 MHz, DMSO-d6) d: 160.23,
158.48, 158.34, 146.27, 132.98, 131.76, 128.50, 120.63,
112.18, 111.98, 99.53, 14.74. HR-MS (ESI-Q-TOF): m/z
C18H13BF3N4- [M-H]- calcd. 353.1185, found 353.1191.
3c: 1H NMR (500 MHz, DMSO-d6) d: 8.32 (s, 1H), 7.87
(d, J = 8.4 Hz, 1H), 7.73 (dd, J = 8.4, 1.5 Hz, 1H), 7.32 (d,
J = 4.2 Hz, 2H), 6.57 (d, J = 4.3 Hz, 2H), 2.60 (s, 6H). 13C
NMR (126 MHz, DMSO-d6) d: 159.07, 148.06, 133.09,
131.76, 127.85, 126.58, 120.88, 119.68, 105.20, 14.79.
HR-MS (ESI-Q-TOF): m/z C19H13BF2N5- [M–H]- calcd.
360.1238, found 360.1239.
1
powders. Yield 380 mg (50%). H NMR (400 MHz,
CDCl3) d: 8.74 (s, 2H), 7.39 (dd, J = 8.8, 4.7 Hz, 1H),
7.15 (dd, J = 8.9, 2.5 Hz, 1H), 6.96 (td, J = 9.2, 2.5 Hz,
1H), 5.94 (t, J = 3.0 Hz, 2H), 5.82–5.81 (m, 2H), 5.62 (s,
1H), 2.21 (s, 6H). HR-MS (ESI-Q-TOF): m/z C18H16FN4-
[M–H]- calcd. 307.1364, found 307.1366.
Preparation of BODIPY (4). A solution of meso-(2-
benzimidazolyl) BODIPY 3a (0.15 mmol, 1.0 equiv.)
in a mixture of 30 mL toluene, p-toluenesulfonic acid
(PTSA) (3 mg) and pyridine (0.2 mL) were placed in a
round-bottom flask equipped with a Dean–Stark trap, and
the mixture was heated under reflux until it evaporated
to dryness. After cooling for 15 min, the resulting
combined solid was dissolved in dichloromethane and
washed with water. The organic layer was dried over
Na2SO4 and evaporated to dryness under vacuum, and the
crude residue was separated by column chromatography
(silica gel, petroleum ether/10% ethyl acetate) and
Compound 2c could not be isolated in pure form,
apparently, because of its high sensitivity to oxidation.
The synthesis follows the general reaction procedure
similar to that of 2b and the reaction time was 6 h.
The crude product, obtained in ca. 35% yield, was
submitted to the next BODIPY synthesis. HR-MS
-
(ESI-Q-TOF): m/z C19H16N5 [M–H]- calcd. 314.1411,
found 314.1402.
Copyright © 2019 World Scientific Publishing Company
J. Porphyrins Phthalocyanines 2019; 23: 6–8